| | ||||||||||
| 1 | INN | Class | Route (list) | PK parameters= Cmax; Tmax; F: bioavailability; t1/2: half-life; VD: volume of distribution; Cl: clearance; PPB: plasma protein binding;(EQN means that value was calculated using VD=(Cl*t1/2)/0.693) | Primary Target and PDB code of Protein-Drug complex | Targets from DrugCentral | Links | |||
| SORAVTANSINE
| SORAVTANSINE MIRVETUXIMAB SORAVTANSINE-GYNX | NATURAL MOLECULE (link) ANTINEOPLASTIC | INJECTION | Cmax 5.2 NANOMOLAR PPB 99 PERCENT Cl 13.8 LITER / HOUR HT 67.2 HOUR | TUBULIN | TUBULIN TBB1_HUMAN INHIBITOR UNIPROT P04350 more at DrugCentral | EMA | |||
